Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5

From the Departments of Psychiatry and Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Psychiatry, McMaster University, Hamilton, Ontario; the Department of Psychiatry, Rush University Medical Center, Chicago; the Department of Pharmacology and the Institute of Physiology and Neuroscience, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden; NIMH Intramural Research Program, Bethesda, Md.; the Department of Psychological Medicine, Cardiff University, Cardiff, U.K.; and the Department of Psychiatry, Yale University, New Haven, Conn.

From the Departments of Psychiatry and Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Psychiatry, McMaster University, Hamilton, Ontario; the Department of Psychiatry, Rush University Medical Center, Chicago; the Department of Pharmacology and the Institute of Physiology and Neuroscience, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden; NIMH Intramural Research Program, Bethesda, Md.; the Department of Psychological Medicine, Cardiff University, Cardiff, U.K.; and the Department of Psychiatry, Yale University, New Haven, Conn.

From the Departments of Psychiatry and Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Psychiatry, McMaster University, Hamilton, Ontario; the Department of Psychiatry, Rush University Medical Center, Chicago; the Department of Pharmacology and the Institute of Physiology and Neuroscience, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden; NIMH Intramural Research Program, Bethesda, Md.; the Department of Psychological Medicine, Cardiff University, Cardiff, U.K.; and the Department of Psychiatry, Yale University, New Haven, Conn.

From the Departments of Psychiatry and Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Psychiatry, McMaster University, Hamilton, Ontario; the Department of Psychiatry, Rush University Medical Center, Chicago; the Department of Pharmacology and the Institute of Physiology and Neuroscience, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden; NIMH Intramural Research Program, Bethesda, Md.; the Department of Psychological Medicine, Cardiff University, Cardiff, U.K.; and the Department of Psychiatry, Yale University, New Haven, Conn.

From the Departments of Psychiatry and Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Psychiatry, McMaster University, Hamilton, Ontario; the Department of Psychiatry, Rush University Medical Center, Chicago; the Department of Pharmacology and the Institute of Physiology and Neuroscience, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden; NIMH Intramural Research Program, Bethesda, Md.; the Department of Psychological Medicine, Cardiff University, Cardiff, U.K.; and the Department of Psychiatry, Yale University, New Haven, Conn.

From the Departments of Psychiatry and Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Psychiatry, McMaster University, Hamilton, Ontario; the Department of Psychiatry, Rush University Medical Center, Chicago; the Department of Pharmacology and the Institute of Physiology and Neuroscience, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden; NIMH Intramural Research Program, Bethesda, Md.; the Department of Psychological Medicine, Cardiff University, Cardiff, U.K.; and the Department of Psychiatry, Yale University, New Haven, Conn.